Tessera Technologies, Inc.
Biotechnology
Tessera Therapeutics is at the forefront of genetic medicine, pioneering Gene Writing™ technology. This innovative approach aims to treat diseases at their genetic roots by writing therapeutic messages directly into the genome. Tessera's mission is to cure diseases by altering the human genome, providing potentially curative and accessible therapies.
Founded: 2018
Michael Severino CEO |
Howard Liang President and CFO |
David Davidson Chief Medical and Development Officer |
Jacob Rubens Co-Founder and Chief Innovation Officer |
Michael Holmes Chief Scientific Officer |
Hari Pujar Chief Operating Officer |
Madhusudan Peshwa Chief Technology Officer |
Iain McFadyen Chief Data Officer |
Becky Lillie Chief Human Resources Officer |
Anna-Virginie Eggimann Chief Regulatory Officer |